Clinical specificities and outcome of LGI1-antibody encephalitis according to age, sex and HLA.

IF 7.5 1区 医学 Q1 CLINICAL NEUROLOGY
Lucia Campetella, Macarena Villagrán-García, Antonio Farina, Marine Villard, Marie Benaiteau, Alberto Vogrig, Raffaele Iorio, Nicolás Lundahl Ciano-Petersen, Dimitri Psimaras, Vincent Navarro, Vicente Peris Sempere, David Gonçalves, Géraldine Picard, Véronique Rogemond, Bastien Joubert, Emmanuel Mignot, Jérôme Honnorat, Sergio Muñiz-Castrillo
{"title":"Clinical specificities and outcome of LGI1-antibody encephalitis according to age, sex and HLA.","authors":"Lucia Campetella, Macarena Villagrán-García, Antonio Farina, Marine Villard, Marie Benaiteau, Alberto Vogrig, Raffaele Iorio, Nicolás Lundahl Ciano-Petersen, Dimitri Psimaras, Vincent Navarro, Vicente Peris Sempere, David Gonçalves, Géraldine Picard, Véronique Rogemond, Bastien Joubert, Emmanuel Mignot, Jérôme Honnorat, Sergio Muñiz-Castrillo","doi":"10.1136/jnnp-2025-335960","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with leucine-rich glioma-inactivated 1 antibody (LGI1-Ab) encephalitis are typically elderly men that often carry human leucocyte antigen (HLA)-<i>DRB1*07:01</i> (≈90%). Herein, we aimed to investigate whether patients with atypical demographic profiles or not carrying <i>DRB1*07:01</i> have distinct clinical manifestations and outcome.</p><p><strong>Methods: </strong>Retrospective chart review of LGI1-Ab patients diagnosed at the French Reference Centre and three other European centres.</p><p><strong>Results: </strong>Among 238 patients included, median age at onset was 66 years (IQR: 60-73), 65% were male, 89% carried <i>DRB1*07:01</i> and 10% <i>DRB1*04:02</i>, another known secondary HLA association. We identified three age groups (young, typical, old) based on percentiles of age distribution. Young (≤51 years) patients were less commonly male (35%, p=0.004), while faciobrachial dystonic seizures (FBDS; 65%, p=0.047) and hyponatraemia (64%, p=0.046) were more frequent in old (≥79 years) patients. Old patients experienced poor outcome (modified Rankin Scale [mRS] >2 at last follow-up) more frequently (64%, p<0.001). There were no significant differences between males and females. <i>DRB1*07:01</i> non-carriers were younger (p=0.005) and less frequently male (47%, p=0.044), while non-carriers of both <i>DRB1*07:01</i> and <i>DRB1*04:02</i> experienced poor outcome more commonly (64%, p=0.005). Older age (adjusted OR: 1.08, 95% CI [1.02 to 1.14], p=0.008), higher mRS at nadir (4.22 [2.46-7.24], p<0.001) and <i>DRB1*07:01</i> non-carrier status (8.39 [1.88-37.44], p=0.005) were independently associated with poor outcome. Moreover, older age (1.08 [1.04-1.11], p<0.001), FBDS (2.20 [1.17-4.13], p=0.014) and hyponatraemia (2.30 [1.22-4.34], p=0.010) were associated with severe encephalitis (mRS >3 at nadir).</p><p><strong>Conclusions: </strong>Age appears to be the main driver of clinical presentation, severity and outcome in LGI1-Ab encephalitis. Remarkably, <i>DRB1*07:01</i> non-carriers are younger, more commonly female and experience poorer prognosis, reflecting a distinct pathophysiology.</p>","PeriodicalId":16418,"journal":{"name":"Journal of Neurology, Neurosurgery, and Psychiatry","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology, Neurosurgery, and Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnnp-2025-335960","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Patients with leucine-rich glioma-inactivated 1 antibody (LGI1-Ab) encephalitis are typically elderly men that often carry human leucocyte antigen (HLA)-DRB1*07:01 (≈90%). Herein, we aimed to investigate whether patients with atypical demographic profiles or not carrying DRB1*07:01 have distinct clinical manifestations and outcome.

Methods: Retrospective chart review of LGI1-Ab patients diagnosed at the French Reference Centre and three other European centres.

Results: Among 238 patients included, median age at onset was 66 years (IQR: 60-73), 65% were male, 89% carried DRB1*07:01 and 10% DRB1*04:02, another known secondary HLA association. We identified three age groups (young, typical, old) based on percentiles of age distribution. Young (≤51 years) patients were less commonly male (35%, p=0.004), while faciobrachial dystonic seizures (FBDS; 65%, p=0.047) and hyponatraemia (64%, p=0.046) were more frequent in old (≥79 years) patients. Old patients experienced poor outcome (modified Rankin Scale [mRS] >2 at last follow-up) more frequently (64%, p<0.001). There were no significant differences between males and females. DRB1*07:01 non-carriers were younger (p=0.005) and less frequently male (47%, p=0.044), while non-carriers of both DRB1*07:01 and DRB1*04:02 experienced poor outcome more commonly (64%, p=0.005). Older age (adjusted OR: 1.08, 95% CI [1.02 to 1.14], p=0.008), higher mRS at nadir (4.22 [2.46-7.24], p<0.001) and DRB1*07:01 non-carrier status (8.39 [1.88-37.44], p=0.005) were independently associated with poor outcome. Moreover, older age (1.08 [1.04-1.11], p<0.001), FBDS (2.20 [1.17-4.13], p=0.014) and hyponatraemia (2.30 [1.22-4.34], p=0.010) were associated with severe encephalitis (mRS >3 at nadir).

Conclusions: Age appears to be the main driver of clinical presentation, severity and outcome in LGI1-Ab encephalitis. Remarkably, DRB1*07:01 non-carriers are younger, more commonly female and experience poorer prognosis, reflecting a distinct pathophysiology.

lgi1抗体脑炎在年龄、性别和HLA上的临床特异性和转归。
背景:富含亮氨酸的胶质瘤失活1抗体(LGI1-Ab)脑炎患者多为老年男性,常携带人白细胞抗原(HLA)-DRB1*07:01(≈90%)。在此,我们旨在研究非典型人口统计学特征或不携带DRB1*07:01的患者是否具有不同的临床表现和结果。方法:回顾性分析在法国参考中心和其他三个欧洲中心诊断的LGI1-Ab患者的图表。结果:238例患者中位发病年龄为66岁(IQR: 60-73), 65%为男性,89%携带DRB1*07:01, 10%携带DRB1*04:02,为已知的另一种继发性HLA关联。我们根据年龄分布的百分位数确定了三个年龄组(年轻、典型、老年)。年轻(≤51岁)患者中男性较少(35%,p=0.004),而老年(≥79岁)患者中面肱肌张力障碍发作(FBDS; 65%, p=0.047)和低钠血症(64%,p=0.046)更为常见。老年患者预后较差(末次随访修正Rankin量表[mRS] >2)的发生率较高(64%,pDRB1*07:01),非携带pDRB1*07:01的患者为年轻人(p=0.005),男性发生率较低(47%,p=0.044),非携带DRB1*07:01和DRB1*04:02的患者预后较差(64%,p=0.005)。年龄较大(调整后OR: 1.08, 95% CI [1.02 ~ 1.14], p=0.008)、最低时较高的mRS(4.22[2.46 ~ 7.24])、pDRB1*07:01非携带者状态(8.39 [1.88 ~ 37.44],p=0.005)与预后不良独立相关。年龄越大(1.08[1.04-1.11],最低点为p3)。结论:年龄似乎是LGI1-Ab脑炎的临床表现、严重程度和预后的主要驱动因素。值得注意的是,DRB1*07:01非携带者较年轻,多为女性,预后较差,反映了独特的病理生理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.70
自引率
1.80%
发文量
888
审稿时长
6 months
期刊介绍: The Journal of Neurology, Neurosurgery & Psychiatry (JNNP) aspires to publish groundbreaking and cutting-edge research worldwide. Covering the entire spectrum of neurological sciences, the journal focuses on common disorders like stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage, and neuropsychiatry, while also addressing complex challenges such as ALS. With early online publication, regular podcasts, and an extensive archive collection boasting the longest half-life in clinical neuroscience journals, JNNP aims to be a trailblazer in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信